Week In Review: Eddingpharm Pays $169 Million For China Rights To Omega-3 Drug
March 01, 2015 at 17:52 PM EST
Eddingpharm, a China in-licensing company, signed a deal worth up to $169 million for China rights to Vascepa®, a prescription omega-3 drug from Amarin Corp and more Pharma/Biotech news.
